Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome

被引:38
|
作者
Lindfors, Perjohan [1 ,3 ,4 ]
Unge, Peter [6 ]
Nyhlin, Henry [5 ]
Ljotsson, Brjann [7 ]
Bjornsson, Einar S. [1 ]
Abrahamsson, Hasse [1 ]
Simren, Magnus [1 ,2 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med, S-41345 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Ctr Person Ctr Care GPCC, S-41345 Gothenburg, Sweden
[3] Sabbatsbergs Hosp, Dept Gastroenterol, S-11382 Stockholm, Sweden
[4] Gavle Cty Hosp, Dept Gastroenterol, Gavle, Sweden
[5] Karolinska Univ Hosp, Dept Gastroenterol, Stockholm, Sweden
[6] Orebro Univ Hosp, Dept Gastroenterol, Orebro, Sweden
[7] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
基金
英国医学研究理事会;
关键词
hypnotherapy; IBS; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; COST-EFFECTIVENESS; STRESS-MANAGEMENT; EXPOSURE; METAANALYSIS; POPULATION; DISORDERS;
D O I
10.3109/00365521.2012.658858
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. Gut-directed hypnotherapy is considered to be an effective treatment in irritable bowel syndrome (IBS) but few studies report the long-term effects. This retrospective study aims to evaluate the long-term perceived efficacy of gut-directed hypnotherapy given outside highly specialized hypnotherapy centers. Methods. 208 patients, who all had received gut-directed hypnotherapy, were retrospectively evaluated. The Subjective Assessment Questionnaire (SAQ) was used to measure changes in IBS symptoms, and patients were classified as responders and non-responders. Patients were also asked to report changes in health-care seeking, use of drugs for IBS symptoms, use of alternative non-pharmacological treatments, and if they still actively used hypnotherapy. Results. Immediately after hypnotherapy, 103 of 208 patients (49%) were responders and 75 of these (73%) had improved further at the follow-up 2-7 years after hypnotherapy (mean 4 years). A majority of the responders still used hypnotherapy on a regular basis at follow-up (73%), and the responders reported a greater reduction in health-care seeking than non-responders. A total of 87% of all patients reported that they considered gut-directed hypnotherapy to be worthwhile, and this differed between responders and non-responders (100% vs. 74%; p < 0.0001). Conclusion. This long-term follow-up study indicates that gut-directed hypnotherapy in refractory IBS is an effective treatment option with long-lasting effects, also when given outside highly specialized hypnotherapy centers. Apart from the clinical benefits, the reduction in health-care utilization has the potential to reduce the health-care costs.
引用
收藏
页码:414 / 421
页数:8
相关论文
共 50 条
  • [21] Efficacy of hypnotherapy in one thousand patients with irritable bowel syndrome
    Dube, S.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1222 - 1223
  • [22] Long term effects of hypnotherapy in refractory IBS
    Lindfors, Perjohan
    Nyhlin, Henry
    Unge, Peter
    Bjornsson, Einar
    Abrahamsson, Hasse
    Simren, Magnus
    GASTROENTEROLOGY, 2008, 134 (04) : A130 - A130
  • [23] Benefits from Long-Term Treatment in Irritable Bowel Syndrome
    Evangelista, Stefano
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [24] HYPNOTHERAPY FOR CHILDREN WITH FUNCTIONAL ABDOMINAL PAIN OR IRRITABLE BOWEL SYNDROME: LONG TERM FOLLOW-UP
    Vlieger, A. M.
    Frankenhuis, C.
    Govers, A.
    Benninga, M. A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E4 - E5
  • [25] Hypnotherapy for Irritable Bowel Syndrome - a Systematic Review
    Hefner, J.
    Rilk, A.
    Herbert, B. M.
    Zipfel, S.
    Enck, P.
    Martens, U.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (11): : 1153 - 1159
  • [26] Tegaserod:: Long-term treatment for irritable bowel syndrome patients with constipation in primary care
    Layer, P
    Keller, J
    Mueller-Lissner, S
    Rüegg, P
    Loeffler, H
    DIGESTION, 2005, 71 (04) : 238 - 244
  • [27] Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome
    Tougas, G
    Snape, WJ
    Otten, MH
    Earnest, DL
    Langaker, KE
    Pruitt, RE
    Pecher, E
    Nault, B
    Rojavin, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1701 - 1708
  • [28] Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation
    Barish, Charles F.
    Crozier, Robert A.
    Griffin, Patrick H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (01) : 81 - 85
  • [29] How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study
    Krouwel, Matthew
    Jolly, Kate
    Greenfield, Sheila
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 45 : 65 - 70
  • [30] Treatment of refractory irritable bowel syndrome with visceral osteopathy: Short-term and long-term results of a randomized trial
    Attali, Thu-Van
    Bouchoucha, Michel
    Benamouzig, Robert
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (12) : 654 - 661